pyrazines has been researched along with Lupus Nephritis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; He, X; Liao, W; Lu, Q; Xiang, W | 1 |
| Berden, JH; van der Vlag, J | 1 |
| Anolik, JH; Barnard, J; Conley, T; Goldman, BI; Ichikawa, HT; Jiang, J; Kirk, CJ; Lee, S; Looney, RJ; Muchamuel, T; Nevarez, S; Owen, T | 1 |
| Amann, K; Benz, K; Daniel, C; Hainz, N; Meister, S; Neubert, K; Rauh, M; Thomas, S; Voll, RE; Wiesener, M | 1 |
| Ma, Y; Pan, HF; Xu, WD; Ye, DQ | 1 |
1 review(s) available for pyrazines and Lupus Nephritis
| Article | Year |
|---|---|
Proteasome inhibition: a new therapeutic option in lupus nephritis?
Topics: Animals; Antibodies, Antinuclear; B-Lymphocytes; Boronic Acids; Bortezomib; Humans; Lupus Nephritis; Mice; Plasma Cells; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines | 2008 |
4 other study(ies) available for pyrazines and Lupus Nephritis
| Article | Year |
|---|---|
CSTMP Exerts Anti-Inflammatory Effects on LPS-Induced Human Renal Proximal Tubular Epithelial Cells by Inhibiting TLR4-Mediated NF-κB Pathways.
Topics: Active Transport, Cell Nucleus; Anti-Inflammatory Agents; Cells, Cultured; Epithelial Cells; Humans; Hydrogen Peroxide; I-kappa B Kinase; Inflammation Mediators; Interleukin-1 Receptor-Associated Kinases; Kidney Tubules, Proximal; Lipopolysaccharides; Lupus Nephritis; MAP Kinase Kinase Kinases; Myeloid Differentiation Factor 88; NF-kappa B; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Oxidative Stress; Phosphorylation; Pyrazines; Stilbenes; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4; Transcription Factor RelA | 2016 |
Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells.
Topics: Animals; Antibody-Producing Cells; Autoantibodies; Boronic Acids; Bortezomib; Disease Progression; Humans; Interferon Type I; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Oligopeptides; Protease Inhibitors; Pyrazines | 2012 |
The proteasome inhibitor bortezomib prevents lupus nephritis in the NZB/W F1 mouse model by preservation of glomerular and tubulointerstitial architecture.
Topics: Animals; Boronic Acids; Bortezomib; Collagen Type IV; Disease Models, Animal; Female; Humans; Immunohistochemistry; Injections, Intravenous; Kidney Glomerulus; Kidney Tubules; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Microscopy, Electron; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Survival Rate; Time Factors; Treatment Outcome | 2012 |
New evidence for the role of proteasome inhibitors in systemic lupus erythematosus: comment on the article by Ichikawa et al.
Topics: Animals; Antibody-Producing Cells; Boronic Acids; Humans; Interferon Type I; Lupus Erythematosus, Systemic; Lupus Nephritis; Oligopeptides; Protease Inhibitors; Pyrazines | 2012 |